期刊文献+

革兰阴性细菌对碳青霉烯类抗生素耐药机制的研究进展 被引量:9

Research progress on the mechanisms of Gram-negative bacteria resistance to carbapenems
原文传递
导出
摘要 目的目前革兰阴性细菌对碳青霉烯类抗生素的耐药形势日趋严峻,耐药率日益增高,菌种类型也从非发酵菌扩大到肠杆菌科细菌。其耐药机制主要以产碳青霉烯酶为主,辅以细菌外膜蛋白通透性降低、主动外排泵功能亢进和药物作用靶点青霉素结合蛋白改变等多种耐药机制协同作用。耐药基因众多,新耐药基因层出不穷,耐药机制复杂,给临床和科研带来了极大挑战。本文主要就革兰阴性细菌耐碳青霉烯类抗生素的机制及耐药菌的流行情况做一简要综述。 Objective Antimicrobial therapy is limited against infections caused by carbapenem-resistant Gram-negative bacteria.The amount of carbapenem-resistant Gram-negative pathogens has significantly increased during the last decade,including the nonfermentaters and Enterobacteriaceae.The mechanisms of drug resistance are mainly due to the production of carbapenemases,as well as the loss of outer membrane proteins(OMPs or porins) and the changes in target bacteria.Penicillin-binding proteins(PBPs) and the presence of over-expressed efflux pumps may also contribute to the drug resistance.Numerous drug-resistant genes,the intricate resistance mechanisms and emerges of new resistant genes have brought great challenges to clinical tests and medical researches.This paper is a summary of current researches on the mechanisms of Gram-negative bacteria resistance to carbapenems and their epidemiology.
作者 蔡壬辛 黄彬
出处 《中国微生态学杂志》 CAS CSCD 2013年第5期612-616,共5页 Chinese Journal of Microecology
关键词 革兰阴性细菌 碳青霉烯类抗生素 碳青霉烯酶 耐药机制 Gram-negative bacteria Carbapenem Carbapenemases Drug-resistant mechanism
  • 相关文献

参考文献40

  • 1LAUTENBACH E,WEINER M G,NACHAMKIN I,et al. Imipenem re- sistance among pseudomonas aeruginosa isolates: risk factors for infec- tion and impact of resistance on clinical and economic outcomes [ J ]. Infect Control Hosp Epidemiol. 2006,27(9) :893-900.
  • 2QUEENAN A M, BUSH K. Carbapenemases:the versatile beta-lacta- mases[ J]. Clin Microbiol Rev. 2007,20(3 ) :440-458.
  • 3LAUTENBACH E, SYNNESTVEDT M, WEINER M G, et al. Epidemi- ology and impact of imipenem resistanee in Aeinetobacter baumannii [ J ]. Infect Control Hosp Epidcmiol. 2009,30 ( 12 ) : 1186-1192.
  • 4WALTHER-RASMUSSEN J, HOIBY N. Oxa-type earbapenemases[ J]. J Antimicrob Chemother. 2006,57 ( 3 ) :373-383.
  • 5AMBLER R P. The stnicture of beta-lactamases [ J]. Philos Trans R Soc Lond B Biol Sci. 1980,289 ( 1036 ) :321-331.
  • 6BUSH K, JACOBY G A. Updated functional classification of beta-lacta- mases [ J ]. Antimicrob Agents Chemother. 2010,54 ( 3 ) :969-976.
  • 7齐艳,俞云松.KPC型碳青霉烯酶研究进展[J].现代实用医学,2010,22(5):485-486. 被引量:11
  • 8WEI Z Q, DU X X,YU Y S,et al. Plasmid-mediated kpc-2 in a Klebsiella pneumoniae isolate from china [ J ]. Antimicrob Agents Chemoth- er. 2007,51 (2) :763-765.
  • 9NAAS T, CUZON G, VILLEGAS M V, et al. Genetic structures at the origin of acquisition of the beta-lactamase bla kpc gene [ J ]. Antimicrob Agents Chemother. 2008,52 (4) : 1257-1263.
  • 10CUZON G, NAAS T,TRUONG H, et al. Worldwide diversity of Kleb- siella pneumoniae that produce beta-lactamase blakpc-2 gene [ J ]. Emerg Infect Dis. 2010,16(9) :1349-1356.

共引文献10

同被引文献90

  • 1徐晓刚,李光辉.抗感染药物在外科领域的预防性应用指南(美国)[J].中国抗感染化疗杂志,2005,5(3):180-183. 被引量:70
  • 2赵晓丽(综述),胡大春(审校).大肠埃希菌耐药机制的研究进展[J].国际检验医学杂志,2007,28(5):438-441. 被引量:14
  • 3李久星 马翠云.头孢菌素类抗生素临床应用及配伍禁忌.山东医药,2002,42(32):77-77.
  • 4杨宝峰.药理学[M].7版.北京:人民卫生出版社,2010:459-460.
  • 5倪语星,尚红.临床微生物学与检验[M].4版.北京:人民卫生出版社,2009.
  • 6倪语星,韩立中.抗菌药物临床应用[M].上海:上海科学技术出版社,2006:55-56.
  • 7A1-Agamy,Shibl AM, Hafez MM, et al. Molecular characteristics of extended-spectrum fl-lactamase producing Escherichia eoli in Riyadh, emergence of CTX-M-15 producing E-coli ST131 [ J]. Ann Clin Microbiol Antimicrob, 2014, 13 ( 1 ) :4-10.
  • 8Cant6n R, Gonz61ez-Alba JM, Gal6n JC. CTX-M enzymes: origin and diffusion [J]. Front Microbiol, 2012,3 : 110-128.
  • 9Zhao WH, Hu ZQ. Epidemiology and genetics of CTX-M extend- ed-spectrum beta-lactamases in Gram-negative bacteria [ J ]. Crit Rev Microbio1,2013,39( 1 ) :79-101.
  • 10Thomson KS. Extended-Spectmm43-Lactamase, AmpC, and Car- bapenemase issues [ J ]. J Clin Microbiol, 2010,48 (4) : 1019- 1025.

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部